Print page
Close print preview
Accedi a banche dati online
| Convegnodetail
PI3K Pathways Summit 2021
Evvnt Promotion / evvnt
Archivio
24.08.2021 - 26.08.2021
Online
Time: 9:00 am - 5:00 pm
Temi della conferenza
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/783356-3?pid=4832
Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/783356-0?pid=4832
Ms. Anita Kelemen
161 07455 4188
info@hansonwade.com
Categorie
Medicina General, Oncologia
Lingua
Inglese
Sito web
go.evvnt.com/783356-2?pid=4832
Quote del Congresso
USD 1349.00 - USD 3397.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
Tel:
+44 0207 3230 450
hello@evvnt.com
evvnt.com/